Document is current
Any future updates will be listed below
-
Authors
Nuerrula, Yiliyaer
Xue, Zhaoyuan
Tiliwalidi, Aidiye
Xiao, Xueling
Dong, Zihao
Liu, Jingkun
Eli, Mayinur
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (82260471, 82260471, 82260471, 82260471, 82260471, 82260471, 82260471)
the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund (SKL-HIDCA-2022-SG4, SKL-HIDCA-2022-SG4, SKL-HIDCA-2022-SG4, SKL-HIDCA-2022-SG4, SKL-HIDCA-2022-SG4, SKL-HIDCA-2022-SG4, SKL-HIDCA-2022-SG4)
the Special Fund for Youth Scientific Research of the First Affiliated Hospital of Xinjiang Medical University (2022YFY-QKQN-94, 2022YFY-QKQN-94, 2022YFY-QKQN-94, 2022YFY-QKQN-94, 2022YFY-QKQN-94, 2022YFY-QKQN-94, 2022YFY-QKQN-94)
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 3 July 2025
First Online: 24 July 2025
Declarations
:
: The authors declare no competing interests.
: Human tissue studies and animal experiments in the present study were approved (approval nos. 20220309–106 and IACUC-JT-20231121–33, respectively) and monitored by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Urumqi, China). Human tissue studies were conducted in accordance with the 1964 Helsinki Declaration and its later amendments of comparable ethical standards. Informed consent was obtained from all patients or their legal guardian, and the data were analysed anonymously throughout the study. I confirm that our animal research study report complies with the ARRIVE guidelines.
